# Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease

> **NCT00865501** · PHASE3 · COMPLETED · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 50 (actual)

## Conditions studied

- Primary Hypertension

## Interventions

- **DRUG:** spironolactone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00865501
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2012-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00865501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00865501, "Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00865501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*